Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Real-World Data & Evidence CollectionPost-Market Safety Registries
Research, Drug Development & Manufacturing

Health Canada Canada Vigilance

Also known as: Canada Vigilance Program

National adverse reaction reporting and access database for marketed health products in Canada. Psychedelic relevance: Health Canada publishes psilocybin-specific clinical-trial and special-access policy notices.

Real-World Data Snapshot

Verified

Verification

Verified

Coverage

1 country

Access Model

Open access

Last Verified

Apr 7, 2026

Methodology

Canada Vigilance aggregates suspected adverse reaction reports for marketed products and makes searchable datasets available for signal review.

Safety monitoring registriesWeeklySafety surveillance data

Primary Dataset

Search Canada Vigilance

Source Evidence

2 sources

Canada Vigilance Adverse Reaction Database

https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-database.html

Health Canada Psilocybin Clinical Trial / SAP Notice

https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-considerations-proposed-use-psilocybin-mushrooms-clinical-trials-special-access-program.html

Quick Facts

Website
Visit